Two Natural ent-kauranoids as Novel Wnt Signaling Inhibitors

Area of Science:

• Natural Products Chemistry
• Molecular Biology
• Oncology

Background:

• Constitutive activation of the Wnt signaling pathway is a hallmark of most colon cancers.
• Targeting the Wnt pathway offers a rational therapeutic strategy for colorectal malignancies.

Purpose of the Study:

• To identify novel inhibitors of the Wnt signaling pathway from a natural ent-kauranoid library.
• To evaluate the therapeutic potential of identified compounds against colon cancer.

Main Methods:

• Dual-luciferase reporter gene assay for Wnt pathway inhibition screening.
• Cell viability assays on colon carcinoma cell lines (SW480, HCT116, HT29) and normal colonic epithelial cells (CCD-841-CoN).
• Flow cytometry for cell cycle analysis (G2/M phase arrest).
• Quantitative analysis of Wnt target gene expression (c-myc, cyclin D1, survivin, Axin2).

Main Results:

• Rabdoternin B and maoecrystal I were identified as Wnt signaling inhibitors.
• Both compounds demonstrated concentration-dependent inhibition of Wnt signaling.
• Selective cytotoxicity was observed against colon cancer cell lines, with minimal impact on normal cells.
• Treatment induced G2/M phase arrest in SW480 cells.
• Maoecrystal I reduced the expression of key Wnt target genes.

Conclusions:

• Rabdoternin B and maoecrystal I are novel inhibitors of the canonical Wnt signaling pathway.
• These compounds exhibit selective anti-cancer activity against colon cancer cells.
• Rabdoternin B and maoecrystal I hold promise as potential therapeutic agents for colon cancer treatment.